Drake M E, Shin C
Arch Neurol. 1983 Jan;40(1):44-6. doi: 10.1001/archneur.1983.04050010064018.
Anticoagulant therapy is appropriate for embolic cerebral infarction due to valvular heart disease or cardiac dysrhythmia, as well as for stroke-in-evolution. Various incidences of hemorrhagic complications have been cited in patients given anticoagulants after stroke or transient cerebral ischemia. Conversion of ischemic to hemorrhagic infarction has been shown to occur experimentally. We describe two patients in whom this conversion occurred in the absence of hypertension or excessive anticoagulation and was substantiated by serial computed tomographic brain scans. This finding suggests that conversion of ischemic to hemorrhagic infarction may occur even with appropriate and carefully administered anticoagulation therapy.
抗凝治疗适用于因心脏瓣膜病或心律失常所致的栓塞性脑梗死,以及进展性卒中。已有文献报道,在卒中或短暂性脑缺血发作后接受抗凝治疗的患者中,出血并发症的发生率各不相同。实验表明,缺血性梗死可转化为出血性梗死。我们描述了两名患者,他们在没有高血压或抗凝过度的情况下发生了这种转化,并且经系列头颅计算机断层扫描得以证实。这一发现提示,即使进行适当且谨慎的抗凝治疗,缺血性梗死仍可能转化为出血性梗死。